Menu
Back to User profile » Dr Bangde Xiang
Papers published by Dr Bangde Xiang:
Development and Validation of a Prediction Model for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients Receiving Postoperative Adjuvant Transarterial Chemoembolization
Tu X, Zhang J, Li M, Lu F, Wang T, Gong W, Xiang B
Journal of Hepatocellular Carcinoma 2023, 10:1881-1895
Published Date: 24 October 2023
High Platelet Count is a Potential Prognostic Factor of the Early Recurrence of Hepatocellular Carcinoma in the Presence of Circulating Tumor Cells
Lu Z, Huang Y, Huang J, Ni HH, Luo T, Wei X, Bai X, Qi L, Xiang B
Journal of Hepatocellular Carcinoma 2023, 10:57-68
Published Date: 14 January 2023
ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
Song R, Huang J, Yang C, Li Y, Zhan G, Xiang B
International Journal of General Medicine 2022, 15:8381-8398
Published Date: 28 November 2022
Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy
Song R, Ni H, Huang J, Yang C, Qin S, Wei H, Luo J, Huang Y, Xiang B
Journal of Inflammation Research 2022, 15:6463-6479
Published Date: 28 November 2022
Developing and Validating an Autophagy Gene-Set-Based Prognostic Signature in Hepatocellular Carcinoma Patients
Zhang J, Zhao J, Wei S, Huang P, Tu X, Su G, Gan Y, Gong W, Xiang B
International Journal of General Medicine 2022, 15:8399-8415
Published Date: 28 November 2022
Combining Pre- and Postoperative Lymphocyte–C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy
Ni HH, Lu Z, Huang X, Ning SW, Liang XL, Zhang SY, Xiang BD
Journal of Inflammation Research 2022, 15:2229-2241
Published Date: 5 April 2022
Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma
Zhang Q, Xing W, Zhang J, Hu J, Qi L, Xiang B
OncoTargets and Therapy 2021, 14:1543-1552
Published Date: 2 March 2021